• Archives of Pharmacal Research
• /
• 제23권5호
• /
• pp.507-512
• /
• 2000

This study set out to improve the physical and pharmaceutical characteristics of the present formulation using an appropriate experimental design. The work described here concerns the formulation of the dispersible tablet applying direct compression method containing roxithromycin in the form of coated granules. In this study $2^3$ factorial design was used as screening test model and Central Composite Design (CCC) associated with response surface methodology was used as optimization study model to develop and to optimize the proper formulation of roxithromycin dispersible tablet. The three independent variables investigated were functional excipients like binder (X1), disintegrant (X2) and lubricant (X3). The effects of these variables were investigated on the following responses: hardness (Y1), friability (Y2) and disintegration time (Y3) of tablet. Three replicates at the center levels of the each design were used to independently calculate the experimental error and to detect any curvature in the response surface. This enabled the best formulations to be selected objectively. The effect order of each term to all response variable was X3> X2> Xl> X1＊X2> X2＊X2> X2＊X3> X3＊X3> Xl＊X3> Xl＊Xl and model equations on each response variables were generated. Optimized compositions of formula were accordingly computed using those model equations and confirmed by following demonstration study. As a result, this study has demonstrated the efficiency and effectiveness of using a systematic formulation optimization process to develop the tablet formulation of roxithromycin dispersible tablet with limited experiment.

• Journal of Pharmaceutical Investigation
• /
• 제40권5호
• /
• pp.297-304
• /
• 2010

The present work focuses on preparation of olanzapine, orally dispersing tablets by direct compression method. Effect of super disintegrant crospovidone, disintegration time, drug content on in vitro release has been studied. A factorial design was employed in formulating a prompt dispersible tablet. The selected independent variables crospovidone and fmelt showed significant effect on dependent variables i.e. disintegration time and percent drug dissolved. Disintegration time and percent drug dissolved decreased with increase in the level of crospovidone. The similarity factor $f_2$ was found to be 97.48 for the developed formulation indicating the release was similar to that of the marketed formulation. Pharmacokinetics of olanzapine after single-dose oral administration of orally disintegrating tablet in normal volunteers were evaluated and the results showed that PK parameters (Cmax, Tmax, AUC) of the designed ODT matrix were similar to those of commercial product, Zyprexa Zydis$^{(R)}$ as a reference.

• 약학회지
• /
• 제49권5호
• /
• pp.392-398
• /
• 2005

In this study, we evaluated the stability of amoxicillin (AMX) and clavulanic acid (CLA) in aqueous solution, and compared the stability of AMX and CLA in commercial combination products. In aqueous solutions, the degradation of AMX ($t_{90}=8.88\;day\;at\;10^{circ}C$) and CLA ($t_{90}=3.53\;day\;at\;10^{circ}C$) occurred rapidly. From the pH-rate profile, AMX and CLA were the most stable at the range of pH 5.5 and 6.0. After reconstitution of commercial dry syrups, the contents of AMX and CLA in suspensions were gradually decreased for 7 days. However, AMX and CLA in dispersible tablet were not changed at all. The contents of CLA in the dispersible tablet ($87.92\%$) and dry syrups (2.16 and $3.91\%$) were remained in the accel­erated stability test ($75\%\;RH,\;at\;40^{circ}C$) after 10 hours. And the colors of the dry syrups were rapidly changed from white to yellow. From these results, we concluded that the dispersible tablet could overcome the stability problems of dry syrups.

• Journal of Pharmaceutical Investigation
• /
• 제33권2호
• /
• pp.85-89
• /
• 2003

Piroxicam-arginine complex was prepared to improve the solubility and dissolution rate of poorly water-soluble piroxicam. Its formation was identified by infrared spectrophotometry, differential thermal analysis and dissolution rate. Piroxicam complex dispersible tablets, commercial $Feldene^{\circledR}$ dispersible tablets and piroxicam physical mixture hard capsules were prepared to compare dissolution rate in water. Dissolved amounts (%) after 15 mins of piroxicam complex dispersible tablets, commercial $Feldene^{\circledR}$ dispersible tablets and piroxicam physical mixture hard capsules were 98%, 48% and 10%, respectively. The solubility of complex in water was significantly higher than that of piroxicam itself. In vivo, pharmacokinetic parameters were obtained after oral administrations of piroxicam complex and physical mixture at a does of 2 mg to New Zealand White Rabbit. The $C_{max}$ of piroxicam complex was similar to that of piroxicam. However, there were much difference between the two formulations with regard to $T_{max}$ and AUC. The $T_{max}$ of piroxicam alone was 4 hours, but that of piroxicam complex was 0.8 hours. In addition, the AUC of piroxicam complex was 1.38 times greater than that of piroxicam alone.

• 한국잡초학회지
• /
• 제31권4호
• /
• pp.384-393
• /
• 2011

Benzobicyclon은 HPPD활성을 억제하여 plastoquinone의 생합성을 저해하며 최종적으로 carotenoid 합성을 억제하고 대상잡초는 백화현상(bleaching)을 거쳐 고사하게 된다. 본 시험은 저항성잡초에 대한 benzobicyclon의 제형별, 증량제 종류별 제초활성을 비교하기 위하여 실시하였다. 폿트 시험에서 SU계 제초제 저항성 올챙이고랭이에 대한 benzobicyclon의 제형별 제초활성은 SC가 GR보다 높게 나타났고 이러한 결과는 시험포장에서도 동일하였는데, 이는 SC의 평균입경이 GR보다 작기 때문이다. 또한 평균입경이 동일한 benzobicyclon 혼합제의 DT와 GR간의 제초활성은 차이는 용출속도에 의해 차이가 나타났다. Benzobicyclon 혼합제 GR를 분쇄방법을 통해 유효성분의 평균입경을 각각 다르게 하여 제초활성을 비교시 습식분쇄를 거쳐 평균입경을 작게 한 GR-II의 제초활성이 높았다. 또한 건식분쇄를 거쳐 증량제를 talc와 bentonite로 사용한 GR-I보다 증량제를 $CaCO_3$와 kaolin을 사용한 GR-III의 제초활성이 10% 높았다. Benzobicyclon 성분을 습식분쇄하여 제형화한 GR의 제초활성이 높은 이유는 benzobicyclon 성분의 평균 입경이 작아 유효성분의 용출이 신속하게 이루어졌기 때문이고, 증량제의 종류에 따른 용출 차이는 benzobicyclon의 광물질의 종류에 따라 흡착(결합)력이 다르기 때문이다. Benzobicyclon 혼합제의 스크린 사이즈가 1mm인 GR-I와 0.7mm인 GR-IV간의 효과차이는 10% 이내이었다.